Similar articles for PMID: 12415594

Year	Number of Results
1963	1
1986	1
1987	1
1990	1
1991	1
1993	1
1994	2
1995	2
1996	6
1997	3
1998	5
1999	4
2000	1
2001	5
2002	4
2003	6
2004	4
2005	7
2006	12
2007	25
2008	15
2009	11
2010	9
2011	18
2012	14
2013	13
2014	13
2015	14
2016	19
2017	13
2018	21
2019	12
2020	21
2021	12
2022	8
2023	2
2024	0

1

Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.

Griffiths B, Miles S, Moss H, Robertson R, Veale D, Emery P. Griffiths B, et al. J Rheumatol. 2002 Nov;29(11):2371-8. J Rheumatol. 2002. PMID: 12415594 Clinical Trial.

2

High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.

Wanchu A, Suryanaryana BS, Sharma S, Sharma A, Bambery P. Wanchu A, et al. Int J Rheum Dis. 2009 Sep;12(3):239-42. doi: 10.1111/j.1756-185X.2009.01417.x. Int J Rheum Dis. 2009. PMID: 20374353 Clinical Trial.

3

A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis.

Vanthuyne M, Blockmans D, Westhovens R, Roufosse F, Cogan E, Coche E, Nzeusseu Toukap A, Depresseux G, Houssiau FA. Vanthuyne M, et al. Clin Exp Rheumatol. 2007 Mar-Apr;25(2):287-92. Clin Exp Rheumatol. 2007. PMID: 17543155 Clinical Trial.

4

Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function.

van den Hombergh WMT, Simons SO, Teesselink E, Knaapen-Hans HKA, van den Hoogen FHJ, Fransen J, Vonk MC. van den Hombergh WMT, et al. Clin Rheumatol. 2018 Oct;37(10):2715-2722. doi: 10.1007/s10067-018-4171-6. Epub 2018 Jul 10. Clin Rheumatol. 2018. PMID: 29987427 Free PMC article.

5

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

Giacomelli R, Valentini G, Salsano F, Cipriani P, Sambo P, Conforti ML, Fulminis A, De Luca A, Farina G, Candela M, Generini S, De Francisci A, Tirri E, Proietti M, Bombardieri S, Gabrielli A, Tonietti G, Cerinic MM. Giacomelli R, et al. J Rheumatol. 2002 Apr;29(4):731-6. J Rheumatol. 2002. PMID: 11950014 Clinical Trial.

6

Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease.

Yiannopoulos G, Pastromas V, Antonopoulos I, Katsiberis G, Kalliolias G, Liossis SN, Andonopoulos AP. Yiannopoulos G, et al. Rheumatol Int. 2007 Feb;27(4):357-61. doi: 10.1007/s00296-006-0217-1. Epub 2006 Sep 22. Rheumatol Int. 2007. PMID: 17021713 Clinical Trial.

7

Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders.

Iudici M, Cuomo G, Vettori S, Bocchino M, Sanduzzi Zamparelli A, Cappabianca S, Valentini G. Iudici M, et al. Semin Arthritis Rheum. 2015 Feb;44(4):437-44. doi: 10.1016/j.semarthrit.2014.09.003. Epub 2014 Sep 8. Semin Arthritis Rheum. 2015. PMID: 25282395

8

Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase.

Airò P, Danieli E, Rossi M, Frassi M, Cavazzana I, Scarsi M, Grottolo A, Franceschini F, Zambruni A. Airò P, et al. Clin Exp Rheumatol. 2007 Mar-Apr;25(2):293-6. Clin Exp Rheumatol. 2007. PMID: 17543156 Clinical Trial.

9

Long-term follow-up of patients with scleroderma interstitial lung disease treated with intravenous cyclophosphamide pulse therapy: a single-center experience.

Balbir-Gurman A, Yigla M, Guralnik L, Hardak E, Solomonov A, Rozin AP, Toledano K, Dagan A, Bishara R, Markovits D, Nahir MA, Braun-Moscovici Y. Balbir-Gurman A, et al. Isr Med Assoc J. 2015 Mar;17(3):150-6. Isr Med Assoc J. 2015. PMID: 25946765 Free article.

10

Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.

Goldin JG, Kim GHJ, Tseng CH, Volkmann E, Furst D, Clements P, Brown M, Roth M, Khanna D, Tashkin DP. Goldin JG, et al. Ann Am Thorac Soc. 2018 Nov;15(11):1286-1295. doi: 10.1513/AnnalsATS.201802-079OC. Ann Am Thorac Soc. 2018. PMID: 30265153 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

257 results

Results by year